WO2023119333 - PROCESS FOR PREPARATION OF RELUGOLIX AND ITS INTERMEDIATES
National phase entry is expected:
Publication Number
WO/2023/119333
Publication Date
29.06.2023
International Application No.
PCT/IN2022/051121
International Filing Date
23.12.2022
Title **
[English]
PROCESS FOR PREPARATION OF RELUGOLIX AND ITS INTERMEDIATES
[French]
PROCÉDÉ DE PRÉPARATION DE RÉLUGOLIX ET DE SES INTERMÉDIAIRES
Applicants **
DR. REDDY’S LABORATORIES LIMITED
Inventors
ORUGANTI, Srinivas
SEN, Saikat
SAMPATH, Magesh
EDA, Vishnu Vardhana Vema Reddy
BUDHDEV, Rehani Rajeev
M, Naga Raju
K, Sreenadha Charyulu
GEDA, Veera Venkata Satyanarayana Chiranjeevi
Priority Data
202141060785
25.12.2021
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1956 | |
| EPO | Filing, Examination, Granting | 11558 | |
| Japan | Filing, Examination, Granting | 1998 | |
| South Korea | Filing, Examination, Granting | 1804 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,056
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present application relates to a process for preparation of relugolix or its pharmaceutically acceptable salts thereof. The present application also relates to the process for preparation of Relugolix crystalline form R1.[French]
La présente invention concerne un procédé de préparation de rélugolix ou de ses sels pharmaceutiquement acceptables. La présente invention concerne également le procédé de préparation de la forme cristalline R1 du rélugolix.